Swarmer’s 520% Debut Gain Ignites Narrow IPO Spotlight
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...
Spreadsheets are powerful tools for investment planning. Discover how to utilize them to track and manage your investments efficiently.
19,873 articlesSwarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...
Mortgage rates surged to a 3-month high, reshaping the investment landscape. A handful of stocks—mortgage servicers, ...
Pfizer stock is signaling a shift after years of underperformance. This article breaks down what’s changing, why it m...
Apple faces a window of opportunity as upbeat quarterly results and expanding services/supporting growth drivers push...
Meta Platforms has shown strong top-line momentum, but rising AI-related costs and shifting margins could pressure ea...
Market fear is loud, but smart investors look for resilient opportunities. Here’s why I’m adding a tech stock to my p...
Bitcoin and XRP lead the 2026 debate on how to deploy $1,000 in crypto, with macro momentum and policy shifts potenti...
Intel and AMD delivered contrasting Q4 results, highlighting divergent paths: Intel grappling with foundry losses ami...
When fear takes the wheel, investors often forget the basics. This guide lays out three practical reminders to stay t...
Beaten-down stocks often hide big upside. Explore a practical, evidence-based approach to identifying a candidate tha...
A pro-Iranian hacking group claims it accessed the personal email of FBI Director Kash Patel, releasing old photos an...
This week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...